Zobrazeno 1 - 10
of 578
pro vyhledávání: '"Long, GV"'
Autor:
Liyanage, U, MacGregor, S, Bishop, DT, Shi, J, An, J, Ong, JS, Han, X, Scolyer, RA, Martin, NG, Medland, SE, Byrne, EM, Green, AC, Saw, RPM, Thompson, JF, Stretch, J, Spillane, A, Jiang, Y, Tian, C, 23andMe Research Team, Gordon, SG, Duffy, DL, Olsen, CM, Whiteman, DC, Long, GV, Iles, MM, Landi, MT, Law, MH
Genome-wide association studies (GWAS) have identified a number of risk loci for cutaneous melanoma. Cutaneous melanoma shares overlapping genetic risk (genetic correlation) with a number of other traits, including with its risk factors such as sunbu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::4e523d2bb9d39da053d71f478e5b29c2
https://eprints.whiterose.ac.uk/181336/7/PIIS0022202X21025136.pdf
https://eprints.whiterose.ac.uk/181336/7/PIIS0022202X21025136.pdf
Publikováno v:
Drug Design, Development and Therapy, Vol 2012, Iss default, Pp 391-405 (2012)
Alexander M Menzies,1 Georgina V Long,1,2 Rajmohan Murali3,41Melanoma Institute Australia, Sydney, New South Wales, Australia; 2Westmead Institute for Cancer Research and Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia;
Externí odkaz:
https://doaj.org/article/a3ce61d430a1478182f296dcdadf7371
Autor:
Eggermont, AMM, Ascierto, PA, Khushalani, NI, Schadendorf, D, Boland, G, Weber, J, Lewis, KD, Johnson, D, Rivalland, G, Khattak, A, Majem, M, Gogas, H, Long, GV, Currie, SL, Chien, D, Tagliaferri, MA, Carlino, MS, Diab, A
Publikováno v:
Future Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Bempegaldesleukin (BEMPEG: NKTR-214) is an immunostimulatory IL-2 cytokine prodrug engineered to deliver a controlled, sustained and preferential IL-2 pathway signal. Nivolumab (NIVO), a PD-L1 inhibitor, has been shown to prolong survival in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::739d4ac04bcc0a4a655b50961c276ab5
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7694
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7694
Autor:
Mangantig, E, MacGregor, S, Iles, MM, Scolyer, RA, Cust, AE, Hayward, NK, Montgomery, GW, Duffy, DL, Thompson, JF, Henders, A, Bowdler, L, Rowe, C, Cadby, G, Mann, GJ, Whiteman, DC, Long, GV, Ward, SV, Khosrotehrani, K, Barrett, JH, Law, MH
Germline genetic variants have been identified, which predispose individuals and families to develop melanoma. Tumor thickness is the strongest predictor of outcome for clinically localized primary melanoma patients. We sought to determine whether th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::72aa7bf86563de9836859f6cf2bc570e
https://eprints.whiterose.ac.uk/176816/3/ddaa222.pdf
https://eprints.whiterose.ac.uk/176816/3/ddaa222.pdf
Autor:
Law, MH, Aoude, LG, Duffy, DL, Long, GV, Johansson, PA, Pritchard, AL, Khosrotehrani, K, Mann, GJ, Montgomery, GW, Iles, MM, Cust, AE, Palmer, JM, Melanoma GWAS Consortium, Shannon, KF, Spillane, AJ, Stretch, JR, Thompson, JF, Saw, RPM, Scolyer, RA, Martin, NG, Hayward, NK, MacGregor, S
Cancers, including cutaneous melanoma, can cluster in families. In addition to environmental aetiological factors such as ultraviolet radiation, cutaneous melanoma has a strong genetic component. Genetic risks for cutaneous melanoma range from rare,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ce9c3edef9be374dbb400fd1d61285cf
Autor:
Smith, Andrea L, Watts, Caroline G, Robinson, Samuel, Schmid, Helen, Goumas, Chris, Mar, Victoria J, Thompson, John F, Rapport, Frances, Cust, Anne E, Braithwaite, J, Gyorki, DE, Henderson, M, Hong, AM, Kelly, JW, Long, GV, Menzies, AM, Morton, RL, Saw, RPM, Scolyer, RA, Spillane, AJ
Publikováno v:
Australasian Journal of Dermatology; May2021, Vol. 62 Issue 2, p168-176, 9p, 2 Diagrams, 4 Charts
Publikováno v:
Nature reviews. Clinical oncology, vol 14, iss 8
Luke, JJ; Flaherty, KT; Ribas, A; & Long, GV. (2017). Targeted agents and immunotherapies: optimizing outcomes in melanoma. NATURE REVIEWS CLINICAL ONCOLOGY, 14(8), 463-482. doi: 10.1038/nrclinonc.2017.43. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0bh4n1vq
Luke, JJ; Flaherty, KT; Ribas, A; & Long, GV. (2017). Targeted agents and immunotherapies: optimizing outcomes in melanoma. NATURE REVIEWS CLINICAL ONCOLOGY, 14(8), 463-482. doi: 10.1038/nrclinonc.2017.43. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0bh4n1vq
Treatment options for patients with metastatic melanoma, and especially BRAF-mutant melanoma, have changed dramatically in the past 5 years, with the FDA approval of eight new therapeutic agents. During this period, the treatment paradigm for BRAF-mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a4ece576c74ba6699662957f7dfecac5
https://escholarship.org/uc/item/0bh4n1vq
https://escholarship.org/uc/item/0bh4n1vq
Autor:
Watts, Caroline, Spillane, Andrew, Henderson, Michael A, Cust, Anne, Braithwaite, J, Gyorki, DE, Hong, AM, Kelly, JW, Long, GV, Mar, VJ, Menzies, AM, Morton, RL, Rapport, F, Saw, RPM, Schmid, H, Scolyer, RA, Smith, AL, Winder, A, Mann, GJ
Publikováno v:
Medical Journal of Australia; Aug2022, Vol. 217 Issue 4, p208-209, 2p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.